Fang Yi-Bin, Li Qiang, Yang Peng-Fei, Huang Qing-Hai, Zhao Wen-Yuan, Xu Yi, Hong Bo, Liu Jian-Min
Department of Neurosurgery of Changhai Hospital affiliated to the Second Military Medical University, Shanghai, PR China.
Clin Neurol Neurosurg. 2013 Jul;115(7):920-5. doi: 10.1016/j.clineuro.2012.09.022. Epub 2012 Oct 4.
Blood blister-like aneurysms (BBAs) are aneurysms arising from the nonbranching arterial trunk, which are usually small and located at the anterior wall of supraclinoid internal carotid artery. These aneurysms are quite dangerous due to their fragile neck. This paper aims to evaluate the application of stent-assisted coil embolization in the treatment of BBAs.
A retrospective review of the aneurysm database in our institution identified 8 patients carrying BBAs planned to be treated by stent-assisted coil embolization. The clinical characteristics, angiographic outcome, and follow-up results were reviewed.
Stent-assisted coil embolization was successfully performed in 5 cases (62.5%). Two procedures were treated with sole stent deployment (25%). One patient suffered intra-operative rupture (12.5%) and endovascular trapping was performed. The modified Rankin scale (mRs) score in living patients at discharge was 1 in four cases, 2 in one case, and 3 in one case. Two patients died of post-operative hemorrhage (25%). The mRs score at 9-36 months' follow-up was 0 in four cases, 1 in one case, and 2 in one case. All patients were followed up angiographically, and regrowth was observed in three patients, who accepted further endovascular treatments.
Stent-assisted coil embolization may probably reduce the mortality, but may not be a cure for all BBAs.
血泡样动脉瘤(BBAs)是起源于非分支动脉干的动脉瘤,通常较小,位于床突上段颈内动脉前壁。这些动脉瘤因其颈部脆弱而相当危险。本文旨在评估支架辅助弹簧圈栓塞术在血泡样动脉瘤治疗中的应用。
对本机构动脉瘤数据库进行回顾性分析,确定8例计划接受支架辅助弹簧圈栓塞术治疗的血泡样动脉瘤患者。回顾其临床特征、血管造影结果及随访结果。
5例(62.5%)成功实施支架辅助弹簧圈栓塞术。2例仅行支架置入术(25%)。1例患者术中破裂(12.5%),行血管内封堵术。出院时存活患者的改良Rankin量表(mRs)评分,4例为1分,1例为2分,1例为3分。2例患者死于术后出血(25%)。9至36个月随访时,mRs评分4例为0分,1例为1分,1例为2分。所有患者均行血管造影随访,3例观察到复发,接受了进一步的血管内治疗。
支架辅助弹簧圈栓塞术可能降低死亡率,但可能无法治愈所有血泡样动脉瘤。